Eli Lilly and Company, a pharmaceutical manufacturer, is releasing a new generic insulin product that is the same product as name-brand Humalog but will cost half as much.
One 100 mg vial of Insulin Lispro will cost $137.35, half the price of name-brand Humalog. Each vial lasts 28 days.
According to a press release from the company, the new version is an attempt to help those buy insulin who can’t afford the name-brand.
“For people with diabetes, a lower-priced insulin can serve as a bridge that addresses gaps in the system until a more sustainable model is achieved,” said Eli Lilly and Company CEO David Ricks in the release.
The almost $140 price tag for a month's supply of insulin is still higher than the estimated $48 to $71 it costs to produce a year's supply of insulin, according to a study done by BMJ Global Health.
